{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-25-000276","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2025-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.405382+00:00","generated_at":"2026-05-26T05:36:55.091630+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"confidence":"high","headline":"Lipella Pharmaceuticals amends placement agent agreement with Spartan Capital Securities","bullets":["Second Amendment removes at-the-market facility restrictions and modifies tail provision to require 10% fee on investments from accredited retail investors within one year of termination.","Mirror Offering capacity increased to $7,200,000 (including $1,200,000 over-allotment) with registration statements due within 30 days of closings.","Variable Rate Transaction restrictions reduced to 90 days post-termination or 10 business days after Registration Statement effective date if $6,000,000 of shares sold.","Company restricted from disposing securities for 90 days after third closing if all shares under that closing are not registered."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-25-000276","json":"https://secwatch.observer/filing/0001753926-25-000276.json","markdown":"https://secwatch.observer/filing/0001753926-25-000276.md","text":"https://secwatch.observer/filing/0001753926-25-000276.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392625000276/0001753926-25-000276-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392625000276/g084711_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-26T05:36:55.091630+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}